Does herbimycin A enhance apoptotic effect of chemotherapeutic drugs on K562 cells?
HMA increases the sensitivity of CML cells to chemotherapeutic agents by inactivating tyrosine kinase activity. It is promising that combination of HMA with conventional chemotherapeutic drugs may be a new strategy in the treatment of CML.
The program described is cost-effective and environmentally beneficial.